Diabetes

Common diabetes drug changes the biology of cancer cells.

Diabesity is quickly transforming into a global health crisis that is no longer limited to developed countries.

Disruptions in circadian rhythm can alter the release of insulin and glucose, causing diabetes.

Metformin shown to alter metabolic pathways of cancer cells.

Overweight patients who experience an inflammatory response are at a higher risk for diabetes.

Adults who have HIV are more likely to develop diabetes than the general population, a study published in BMJ Open Diabetes Research & Care estimates.

Researchers at Kaiser Permanente suggest that triglyceride-lowering therapy in patients with type 2 diabetes can decrease medical costs in a new study published in the American Journal of Cardiology.

Recommendations for screening, diagnosis, management, and treatment for the specific forms are also included in the position paper.

A new partnership between academia and pharmaceutical industries aims to improve diabetes treatment.

Top news of the day from across the health care landscape.

New index more precisely determines the probability of reducing liver fat during lifestyle interventions.

The microbiome and inflammatory signature differs in patients with type 1 diabetes.

Diabetes-related outcomes significantly differ by state and insurance type.

Early-onset schizophrenia may predict a diabetes diagnosis.

Top news of the day from across the health care landscape.

Novel device can determine if a patient has pre-, type 1, or type 2 diabetes.

Increasing expression of hedgehog proteins may lead to speedier healing in patients with diabetes.

The prevalence of diabetes is 17% higher in rural areas than in urban areas.

A recent study indicates that continuous medication monitoring (CoMM) could serve as a valuable tool for community pharmacists, shifting the focus from dispensing to improving patient outcomes and medication use.

As outcomes-based contracting becomes more important, companies are aligning to promote the payment model.

Researchers in England set out to determine whether the risk of diabetes development was present at the onset of schizophrenia, as opposed to after a period of time with the illness.

The diabetic effects on surgical outcomes found to be overstated.

Individuals enrolled in high-deductible health plans face thousands in out of pocket costs.

Individuals with chronic diseases and high-deductible health insurance spend more than 10% on out-of-pocket costs.

Suliqua receives marketing authorization in the EU shortly after the product was approved in the United States as Soliqua.